[go: up one dir, main page]

CA2221455C - Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids - Google Patents

Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids Download PDF

Info

Publication number
CA2221455C
CA2221455C CA002221455A CA2221455A CA2221455C CA 2221455 C CA2221455 C CA 2221455C CA 002221455 A CA002221455 A CA 002221455A CA 2221455 A CA2221455 A CA 2221455A CA 2221455 C CA2221455 C CA 2221455C
Authority
CA
Canada
Prior art keywords
carnosine
derivatives
branched
amino acids
carnitine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002221455A
Other languages
English (en)
French (fr)
Other versions
CA2221455A1 (en
Inventor
Roberto Bianchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau HealthScience SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau HealthScience SpA filed Critical Sigma Tau HealthScience SpA
Publication of CA2221455A1 publication Critical patent/CA2221455A1/en
Application granted granted Critical
Publication of CA2221455C publication Critical patent/CA2221455C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
CA002221455A 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids Expired - Fee Related CA2221455C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI95A001021 1995-05-19
ITMI951021A IT1275434B (it) 1995-05-19 1995-05-19 Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
PCT/EP1996/002079 WO1996036348A1 (en) 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids

Publications (2)

Publication Number Publication Date
CA2221455A1 CA2221455A1 (en) 1996-11-21
CA2221455C true CA2221455C (en) 2008-07-08

Family

ID=11371632

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002221455A Expired - Fee Related CA2221455C (en) 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids

Country Status (11)

Country Link
US (1) US5866537A (it)
EP (1) EP0825871B1 (it)
JP (1) JP4850986B2 (it)
AT (1) ATE204479T1 (it)
AU (1) AU697990B2 (it)
CA (1) CA2221455C (it)
DE (1) DE69614681T2 (it)
ES (1) ES2159737T3 (it)
IT (1) IT1275434B (it)
PT (1) PT825871E (it)
WO (1) WO1996036348A1 (it)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69535104T2 (de) * 1994-11-08 2007-02-08 Avicena Group, Inc., Cambridge Verwendung von kreatin oder kreatinanologen zur behandlung von huntington chorea, morbus parkinson und amyotrophen lateralsklerose
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US8128955B2 (en) 1996-05-31 2012-03-06 The Original Creatine Patent Company Food compositions containing creatine
US7150880B2 (en) 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
US6524611B2 (en) 1996-05-31 2003-02-25 The Howard Foundation Compositions containing creatine and creatinine
GB9611356D0 (en) * 1996-05-31 1996-08-07 Howard Alan N Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
US6168802B1 (en) 1996-05-31 2001-01-02 The Howard Foundation Compositions containing creatine and aloe vera extract
US6274161B1 (en) 1996-05-31 2001-08-14 The Howard Foundation Compositions containing creatine in suspension
DE19649891C2 (de) * 1996-12-02 1998-12-10 Mk Produktkontor Gmbh Verwendung von antioxidativen Zusammensetzungen mit Süßmolkekonzentrat
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
DE19806890A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische und dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Antioxidans sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
US20060128671A1 (en) * 1998-04-02 2006-06-15 The General Hospital Corporation Compositions containing a combination of a creatine compound and a second agent
EP1065931A4 (en) * 1998-04-02 2006-10-11 Avicena Group Inc COMPOSITIONS CONTAINING CREATINE COMBINED WITH A SECOND AGENT
IT1299191B1 (it) * 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
CA2338638C (en) * 1998-07-30 2009-03-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
WO2000007607A1 (en) * 1998-08-04 2000-02-17 Kosbab, John, V. Nutrient and therapeutic compositions for the treatment of cancer
IT1302863B1 (it) * 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
NO993678L (no) * 1999-07-28 2001-01-29 Norsk Hydro As Fôr for salmonider
US6294579B1 (en) 1999-10-11 2001-09-25 Joseph W. Carnazzo Method for improving delivery of tyrosine supplementation
AUPQ515000A0 (en) * 2000-01-19 2000-02-10 Grigg, Geoffrey Walter Treatment of uv induced immunosuppression
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
US6476010B2 (en) 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
IT1317008B1 (it) * 2000-04-04 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare energizzante sulla muscolatura scheletrica eprotettivo sull'apparato cardiovascolare.
US8252309B2 (en) * 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
KR100868592B1 (ko) * 2000-09-14 2008-11-13 보드 오브 리젠츠 오브 디 유니버시티 오브 네브라스카 크레아틴 에스터 전영양소 화합물과 제형
US20030212136A1 (en) 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
DE60212015T2 (de) * 2001-03-16 2006-11-02 Suntory Ltd. Autonomsystem kontrollagentien und gesundheitsgetränke und -nahrungsmittel
JP2005528424A (ja) * 2002-06-04 2005-09-22 アビセナ グループ インコーポレイティッド 脳内エネルギー代謝を調節することによって認知機能障害を治療する方法
US6793193B2 (en) * 2002-08-20 2004-09-21 Dart Industries Inc. Adjustable mold for forming shaped food
WO2004028536A1 (en) * 2002-09-30 2004-04-08 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
US20060116328A1 (en) * 2003-01-20 2006-06-01 Babizhayev Mark A Combined use of carnosinase inhibitor with l-carnosines and composition
EP2233127B1 (de) 2004-03-17 2020-05-27 Stada Arzneimittel Ag Verwendung von Antioxidantien zur Herstellung einer pharmazeutischen oder kosmetischen Zusammensetzung zum Schutz der Haut gegen Schädigung durch Infrarot-Strahlung
WO2005120543A1 (en) 2004-06-08 2005-12-22 Flamma, S.P.A. Compositions containing d-carnosine
JP2006052186A (ja) * 2004-08-16 2006-02-23 Toagosei Co Ltd 新規ジヒドロフェルラ酸縮合物
WO2006026304A1 (en) * 2004-08-25 2006-03-09 Ivax Corporation Cardioprotective formulations and uses thereof
EP1883406B1 (en) 2005-05-23 2016-07-06 Natural Alternatives International, Inc. Compositions and methods for the sustained release of beta-alanine
US20070292403A1 (en) * 2006-05-11 2007-12-20 Avicena Group, Inc. Methods of treating a neurological disorder with creatine monohydrate
US9421262B2 (en) * 2009-10-28 2016-08-23 Biomed Research & Technologies, Inc. Compositions and methods for treating dermatological conditions
WO2011078204A1 (ja) * 2009-12-24 2011-06-30 浜理薬品工業株式会社 高脂血症の予防または治療剤、および抗疲労剤
BR112013016021A2 (pt) * 2010-12-21 2018-12-11 Nestec Sa métodos e composições adequadas para gerenciar glicemia em animais
US9233099B2 (en) 2012-01-11 2016-01-12 University Of Cincinnati Methods of treating cognitive dysfunction by modulating brain energy metabolism
JP2014114244A (ja) * 2012-12-11 2014-06-26 Ito En Ltd 抗疲労剤組成物
JP6401028B2 (ja) * 2014-11-27 2018-10-03 Ｓｈｉｏｄａライフサイエンス株式会社 鯨筋肉抽出物からなる中長期記憶障害予防改善剤
JP2016130229A (ja) * 2015-01-15 2016-07-21 有限会社アント アミノ酸溶解物の製造方法および該製造方法により製造したアミノ酸溶解物
FR3056381B1 (fr) * 2016-09-26 2019-11-15 Futur Optimal Composition comprenant de la carnosine
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2019036471A1 (en) 2017-08-14 2019-02-21 Axcella Health Inc. AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 筋肉中の脂肪浸潤の治療のための組成物及び方法
US20220218640A1 (en) * 2021-01-14 2022-07-14 Rob Dickerman Amino acid delivery system
JP2023156812A (ja) * 2022-04-13 2023-10-25 サントリーホールディングス株式会社 組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1240336B (it) * 1990-03-21 1993-12-07 Setra Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica

Also Published As

Publication number Publication date
DE69614681T2 (de) 2002-07-04
JP4850986B2 (ja) 2012-01-11
ITMI951021A0 (it) 1995-05-19
IT1275434B (it) 1997-08-07
AU5897496A (en) 1996-11-29
WO1996036348A1 (en) 1996-11-21
JPH11505540A (ja) 1999-05-21
EP0825871B1 (en) 2001-08-22
ATE204479T1 (de) 2001-09-15
PT825871E (pt) 2001-12-28
EP0825871A1 (en) 1998-03-04
AU697990B2 (en) 1998-10-22
ITMI951021A1 (it) 1996-11-19
US5866537A (en) 1999-02-02
DE69614681D1 (de) 2001-09-27
CA2221455A1 (en) 1996-11-21
ES2159737T3 (es) 2001-10-16

Similar Documents

Publication Publication Date Title
CA2221455C (en) Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
EP1455603B1 (en) Stimulation of in vivo production of proteins with formulation comprising leucine
US10052298B2 (en) Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine
AU669252B2 (en) Medical foods for the nutritional support of child/adult metabolic diseases
US6521591B1 (en) Pharmaceutical composition for muscular anabolism
US6903136B2 (en) Food supplements containing 4-hydroxyisoleucine and creatine
US8703819B2 (en) Use of guanidinoacetic acid (salts) combination with betaine and/or choline to produced an agent that is beneficial to health
JP2006510711A5 (it)
CZ24999A3 (cs) Farmaceutický prostředek
CA2600890A1 (en) Salts, addition compounds and complex compounds of guanidinoacetic acid
CA2667667C (en) Solid or aqueous alkaline preparation comprising a creatine component, process for the production thereof and the use thereof
US20130096193A1 (en) Creatine beta-alaninate: a novel salt for increasing athletic performance
JPH05344863A (ja) 糖尿病に有効な組成物
US7511173B2 (en) Creatine salt with enhanced nutritional and therapeutic efficacy and compositions containing same

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160516